AKT Health announces distribution and promotion partnership for Certara

Tokyo, Japan - AKT Health Analytics, a healthcare and life sciences strategy consulting firm, has announced its partnership with Certara, a global leader in biosimulation software technology, and services. This partnership will allow AKT Health to become the distributor and promoter of Certara’s innovative solutions in the field of model-informed drug development and regulatory science in Japan, India, Sri Lanka, Bangladesh, and Pakistan region.

Certara is a leading provider of simulation and modeling software for the healthcare industry, offering innovative solutions that support drug development, personalized medicine, and regulatory science. Certara software enables researchers, pharmaceutical companies, and regulatory agencies to make informed decisions about drug development, pharmacology, and clinical outcomes.

Mr. Roger Williams, Vice President, Asia Pacific- Certara, said, “AKT Health had been chosen as the preferred distribution and promotional partner for Certara in Japan including India, Sri Lanka, Bangladesh, and Pakistan region. Certara is happy to partner with AKT Health, as they have a successful track record in the biopharmaceutical and medical device industry and a comprehensive understanding of the healthcare market, which will help us to achieve long-term high performance, and growth and maintain corporate and brand results. The collaboration will enable us to broaden our reach and offer our innovative solutions to a wider audience in the pharma and clinical trials sector, which will result in new customer acquisition and drive Certara growth.”

AKT Health is proud to announce that it has entered into an agreement with Certara to become the distribution and promotional partner for its cutting-edge software solutions. 

AKT Health is a specialized strategic consulting company that concentrates on the healthcare and life sciences industries. As the distributor and promoter for Certara, we are committed to developing market-leading strategies for long-term top performance, growth, and sustainability, we will be able to bring their industry-leading technology, expertise, and cutting-edge solutions to organizations, helping pharmaceutical organizations make informed decisions in the Life Science and healthcare industry. Our aim is to help organizations optimize their operations, maximize their profits, and establish themselves as reputable players in the healthcare industry.

AKT Health Analytics will be distributing and promoting the following software  as a component of this partnership:

• Phoenix WinNonlin
• Phoenix NLME
• Phoenix IVIVC Toolkit
• D360 Scientific informatics platform
• Integral data repository
• BaseCase
• GlobalSubmit eCTD
• Pirana modeling workbench
• R speaks NLME（RsNLME）
• Trial Simulator
• Synchrogenix Writer